Mortality Trends from Urologic Cancers in Europe over the Period 1980–2017 and a Projection to 2025

Bosetti, 2011, Trends in mortality from urologic cancers in Europe, 1970–2008, Eur Urol, 60, 1, 10.1016/j.eururo.2011.03.047 Carioli, 2020, European cancer mortality predictions for the year 2020 with a focus on prostate cancer, Ann Oncol, 31, 650, 10.1016/j.annonc.2020.02.009 Cai, 2020, Estimates of over-time trends in incidence and mortality of testicular cancer from 1990 to 2030, Transl Androl Urol, 9, 182, 10.21037/tau.2020.02.22 Culp, 2020, Recent global patterns in prostate cancer incidence and mortality rates, Eur Urol, 77, 38, 10.1016/j.eururo.2019.08.005 Burger, 2013, Epidemiology and risk factors of urothelial bladder cancer, Eur Urol, 63, 234, 10.1016/j.eururo.2012.07.033 Cumberbatch, 2016, The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks, Eur Urol, 70, 458, 10.1016/j.eururo.2015.06.042 Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. In press. https://doi.org/10.1002/ijc.33588. World Health Organization, 1992 World Health Organization Statistical Information System. WHO mortality database. Geneva, Switzerland: World Health Organization; https://www.who.int/data/data-collection-tools/who-mortality-database. World Health Organization Statistical Information System. Health statistics and health information systems. WHO mortality database: tables. Estimated coverage of mortality data. https://wwwwhoint/healthinfo/statistics/morttables/en/. National Cancer Institute. Joinpoint regression program, version 4.1. Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z Clegg, 2009, Estimating average annual per cent change in trend analysis, Stat Med, 28, 3670, 10.1002/sim.3733 Carroll, 2018, NCCN guidelines updates: prostate cancer and prostate cancer early detection, J Natl Compr Canc Netw, 16, 620, 10.6004/jnccn.2018.0036 Litwin, 2017, The diagnosis and treatment of prostate cancer: a review, JAMA, 317, 2532, 10.1001/jama.2017.7248 Butler, 2020, Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment, Br J Cancer, 123, 487, 10.1038/s41416-020-0859-x Negoita, 2018, Annual report to the nation on the status of cancer, part II: recent changes in prostate cancer trends and disease characteristics, Cancer, 124, 2801, 10.1002/cncr.31549 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 US Preventive Services Task Force, 2018, Screening for prostate cancer: US Preventive Services Task Force recommendation statement, JAMA, 319, 1901, 10.1001/jama.2018.3710 Jemal, 2021, Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening, J Natl Cancer Inst, 113, 64, 10.1093/jnci/djaa068 Scelo, 2021, Cancers emerging early in adulthood: analysis of trends and patterns in European cancer registries, Eur J Cancer, 143, 33, 10.1016/j.ejca.2020.10.026 Scott, 2020, Trends in cancer incidence in US adolescents and young adults, 1973–2015, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.27738 Gurney, 2019, International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries, Eur Urol, 76, 615, 10.1016/j.eururo.2019.07.002 Znaor, 2014, International variations and trends in testicular cancer incidence and mortality, Eur Urol, 65, 1095, 10.1016/j.eururo.2013.11.004 Znaor, 2012, Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West, Acta Oncol, 51, 956, 10.3109/0284186X.2012.681701 Trama, 2015, Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: results from the EUROCARE-5 study, Eur J Cancer, 51, 2206, 10.1016/j.ejca.2015.07.027 Znaor, 2020, Testicular cancer incidence predictions in Europe 2010–2035: a rising burden despite population ageing, Int J Cancer, 147, 820, 10.1002/ijc.32810 Santucci, 2020, Progress in cancer mortality, incidence, and survival: a global overview, Eur J Cancer Prev, 29, 367, 10.1097/CEJ.0000000000000594 Antoni, 2017, Bladder cancer incidence and mortality: a global overview and recent trends, Eur Urol, 71, 96, 10.1016/j.eururo.2016.06.010 Nadal, 2019, Management of metastatic bladder cancer, Cancer Treat Rev, 76, 10, 10.1016/j.ctrv.2019.04.002 Babjuk, 2013, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Eur Urol, 64, 639, 10.1016/j.eururo.2013.06.003 Cumberbatch, 2018, Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018, Eur Urol, 74, 784, 10.1016/j.eururo.2018.09.001 Bafunno, 2019, Tobacco control in Europe: a review of campaign strategies for teenagers and adults, Crit Rev Oncol Hematol, 138, 139, 10.1016/j.critrevonc.2019.01.022 Huang J, Leung DK, Chan EO, et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.12.020. Perez-Farinos, 2006, Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981–2000, BMC Public Health, 6, 119, 10.1186/1471-2458-6-119 Levi, 2008, The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int, 101, 949, 10.1111/j.1464-410X.2008.07451.x Dy, 2017, Global burden of urologic cancers, 1990–2013, Eur Urol, 71, 437, 10.1016/j.eururo.2016.10.008 Molarius, 2001, Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA project, Am J Public Health, 91, 206, 10.2105/AJPH.91.2.206 Weikert, 2008, Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition, Am J Epidemiol, 167, 438, 10.1093/aje/kwm321 Moore, 2010, Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants, Cancer Res, 70, 6527, 10.1158/0008-5472.CAN-09-4167 Dalmartello, 2020, Dietary patterns in Italy and the risk of renal cell carcinoma, Nutrients, 12, 134, 10.3390/nu12010134 Bai, 2020, The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017, Exp Hematol Oncol, 9, 27, 10.1186/s40164-020-00181-3 Boffetta, 2014, 57 Horn, 2020, Epidemiology of liver metastases, Cancer Epidemiol, 67, 10.1016/j.canep.2020.101760 Ryan C, Stoltzfus KC, Horn S, et al. Epidemiology of bone metastases. Bone. In press. https://doi.org/10.1016/j.bone.2020.115783:115783. Gosain, 2020, COVID-19 and cancer: a comprehensive review, Curr Oncol Rep, 22, 53, 10.1007/s11912-020-00934-7 Lai, 2020, Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study, BMJ Open, 10, 10.1136/bmjopen-2020-043828 Gheorghe, 2021, Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID -19 pandemic: a national population-based modelling study in England, UK, Eur J Cancer, 10.1016/j.ejca.2021.04.019 Kregting, 2021, Effects of cancer screening restart strategies after COVID-19 disruption, Br J Cancer, 124, 1516, 10.1038/s41416-021-01261-9